American Society of Hirudotherapy

Pharmacy Board of Sierra Leone — Ministry of Health and Sanitation

Sierra Leone PBSL · Sierra Leone · africa

Regulatory jurisdiction profileJurisdictional reference
Unregulatednational regulator

Sierra Leone Pharmacy Board — leech-specific authorisation pathway not independently verified by ASH.

Regulatory Profile

Agency type
national regulator
Region
africa
Country
Sierra Leone
Leech status
unregulated
Last ASH review
2026-05-28

Relevant Regulation Codes

  • Sierra Leone Pharmacy and Drugs Act 2001 and amendments
  • ECOWAS Pharmaceutical Regulatory Harmonisation arrangements where applicable

Prescriber Requirements

  • Sierra Leone Medical and Dental Council–registered physician — order required for any biomedical device application
  • Allied health professional application under physician supervision per institutional protocol

Supply Chain & GMP

Sierra Leone PBSL registration as applicable; English-language labelling (Krio secondary per local convention). Standard cold-chain conditions, with logistical constraints typical of West-African distribution.

Import/Export Rules

Sierra Leone PBSL and Ministry of Agriculture and Forestry Quarantine clearance for live invertebrates; CITES Appendix II paperwork for Hirudo medicinalis / verbana.

Reimbursement Context

Sierra Leone's Free Health Care Initiative coverage depends on inpatient bundling; outpatient hirudotherapy is generally not separately reimbursed.

ASH Editorial Notes

Leech-specific authorisation pathway not independently verified by ASH; falls under general medical-device / traditional-medicine framework as appropriate.

Related Jurisdictions

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.